Apogee Therapeutics Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Apogee Therapeutics stock has a consensus rating of "Hold" and an average price target of $130.53. The average 1-year stock price forecast is 2.20% lower than the current stock price, while the lowest is $81 (-39.31%) and the highest is $137 (+2.64%).

Price Target: $130.53 (-2.20%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$81	$130.53	$135	$137
Change	-39.31%	-2.20%	+1.15%	+2.64%

Analyst Ratings

The average analyst rating for Apogee Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	14	14	14	14	15	3
Buy	0	0	0	0	0	0
Hold	2	2	3	3	4	12
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	17	17	19	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Alex Thompson CFA Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $133	Buy	Maintains	$133	-0.35%	Jun 29, 2026
Joseph Catanzaro Mizuho Securities	Mizuho Securities	Hold Downgrades $110 → $135	Hold	Downgrades	$110 → $135	+1.15%	Jun 24, 2026
Tyler Van Buren TD Cowen	TD Cowen	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 23, 2026
Seamus Fernandez Guggenheim	Guggenheim	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 23, 2026
Geoff Meacham Citi	Citi	Hold Downgrades $125 → $135	Hold	Downgrades	$125 → $135	+1.15%	Jun 23, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

9.09M

Revenue Next Year

12.50M

from 9.09M

37.50%

from 9.09M

EPS This Year

-4.41

from -4.22

EPS Next Year

-5.19

from -4.41

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	9.09M
Operating Income	-33.52M	-93.00M	-216.87M	-285.60M	-349.97M
Net Income	-43.40M	-83.99M	-182.15M	-255.84M	-317.52M
EPS	-	-	-	-4.22	-4.41
Free Cash Flow	-	-45.50M	-113.42M	-138.98M	-274.76M
No. Analysts	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	100.0M
Avg	9.1M
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	1,000.0%
Avg	37.5%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-3.25
Avg	-4.41
Low	-5.00

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-